Meta facebook tracking pixel

Listen Now

Topics Covered

  • Review of Chronic Lymphocytic Leukemia, in the Context of COVID-19
  • Significant Role of Testing in Informing Your Treatment Choices
  • First Line Treatment Options
  • Treatment of Relapsed and Refractory CLL
  • Re-Testing Importance in Determining Treatment for 2nd and 3rd Line Treatments
  • Current Perspectives on New and Emerging Treatments of CLL
  • Updates on Clinical Trials and Their Significance for CLL
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & Making Your List of Questions
  • Practical Support to Cope with CLL
  • Questions for Our Panel of Experts

Our Panel of Experts


Jennifer R. Brown, MD, PhD

Professor of Medicine, Harvard Medical School, Director, CLL Center, Dana Farber Cancer Institute


Mazyar Shadman, MD, MPH

Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology Division, University of Washington, Attending Physician, Seattle Cancer Care Alliance


Patricia Koffman

Co-Founder & Communications Director CLL Society Inc.


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on April 08, 2021.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.